I agree that this site is using cookies. You can find further informations here.
X
Ruolun Qiu
28  results:
Search for persons X
?
1

Employing zero-inflated beta distribution in an exposure-re..:

Tsamandouras, Nikolaos ; Qiu, Ruolun ; Hughes, Jim H....
Journal of Pharmacokinetics and Pharmacodynamics.  51 (2024)  3 - p. 265-277 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Phase 2 study of the efficacy and safety of ponsegromab in ..:

Groarke, John D. ; Crawford, Jeffrey ; Collins, Susie M....
Journal of Cachexia, Sarcopenia and Muscle.  15 (2024)  3 - p. 1054-1061 , 2024
Link: https://doi.org/10.1002/..
 
?
3

A phase 1 study to investigate the absorption, distribution..:

Qiu, Ruolun ; Sharma, Raman ; Wei, Hua...
British Journal of Clinical Pharmacology.  89 (2023)  10 - p. 3056-3066 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib..:

Mease, Philip ; Helliwell, Philip ; Silwinska‐Stanczyk, Paula...
Arthritis & Rheumatology.  75 (2023)  8 - p. 1370-1380 , 2023
Link: https://doi.org/10.1002/..
 
?
5

A phase 2a, randomized, double‐blind, placebo‐controlled, t..:

Saxena, Aditi R. ; Lyle, Stephanie‐An ; Khavandi, Kaivan...
Diabetes, Obesity and Metabolism.  25 (2023)  4 - p. 992-1001 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Study of the ketohexokinase inhibitor PF‐06835919 as a clin..:

Qiu, Ruolun ; Fonseca, Kari ; Bergman, Arthur...
Clinical and Translational Science.  17 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
7

Population Pharmacokinetics of Oral Brepocitinib in Healthy..:

Hughes, Jim H. ; Qiu, Ruolun ; Banfield, Christopher..
Clinical Pharmacology in Drug Development.  11 (2022)  12 - p. 1447-1456 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretas..:

Ahn, Jae Eun ; Carrieri, Charles ; Dela Cruz, Fernando...
Clinical Pharmacology & Therapeutics.  107 (2019)  1 - p. 211-220 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic..:

Qiu, Ruolun ; Ahn, Jae Eun ; Alexander, Robert...
Journal of Alzheimer's Disease.  71 (2019)  2 - p. 581-595 , 2019
Link: https://doi.org/10.3233/..
 
?
10

Pharmacology in translation: the preclinical and early clin..:

Nickolls, Sarah A ; Gurrell, Rachel ; van Amerongen, Guido...
British Journal of Pharmacology.  175 (2018)  4 - p. 708-725 , 2018
Link: https://doi.org/10.1111/..
 
?
11

[O2–17–04]: PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) EFFECTS..:

Ahn, Jae Eun ; Liu, Richann ; Trapa, Patrick...
Alzheimer's & Dementia.  13 (2017)  7S_Part_12 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
12

[O2–09–05]: SAFETY, TOLERABILITY, AND PHARMACOKINETIC AND P..:

Qiu, Ruolun ; Liu, Richann ; He, Ping...
Alzheimer's & Dementia.  13 (2017)  7S_Part_11 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
13

P2‐009: PF‐06648671–A Novel Gamma Secretase Modulator: Safe..:

Qiu, Ruolun ; Liu, Richann ; Wills, Anne-Marie...
Alzheimer's & Dementia.  12 (2016)  7S_Part_12 - p. , 2016
Link: https://doi.org/10.1016/..
 
?
14

Minimization of CYP2D6 Polymorphic Differences and Improved..:

Chew, Marci L. ; Mordenti, Joyce ; Yeoh, Thean...
Pharmaceutical Research.  33 (2016)  8 - p. 1873-1880 , 2016
Link: https://doi.org/10.1007/..
 
?
15

P3‐376: Advancement of a drug‐disease trial model for Alzhe..:

Romero, Klaus ; Stephenson, Diane ; Rogers, James...
Alzheimer's & Dementia.  8 (2012)  4S_Part_16 - p. , 2012
Link: https://doi.org/10.1016/..
 
1-15